Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.
Identifieur interne : 006555 ( Main/Merge ); précédent : 006554; suivant : 006556Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.
Auteurs : Yossef Kliger [Israël] ; Erez Y. LevanonSource :
- BMC microbiology [ 1471-2180 ] ; 2003.
Descripteurs français
- KwdFr :
- Agents antiVIH (pharmacologie), Antiviraux (pharmacologie), Conception de médicament, Conformation des protéines, Données de séquences moléculaires, Fragments peptidiques (pharmacologie), Protéine d'enveloppe gp41 du VIH (pharmacologie), Protéines de fusion virale (), Protéines de fusion virale (génétique), Protéines de fusion virale (métabolisme), VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (), Virus du SRAS ().
- MESH :
- génétique : Protéines de fusion virale.
- métabolisme : Protéines de fusion virale.
- pharmacologie : Agents antiVIH, Antiviraux, Fragments peptidiques, Protéine d'enveloppe gp41 du VIH.
- Conception de médicament, Conformation des protéines, Données de séquences moléculaires, Protéines de fusion virale, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Virus du SRAS.
English descriptors
- KwdEn :
- Anti-HIV Agents (pharmacology), Antiviral Agents (pharmacology), Drug Design, Enfuvirtide, HIV Envelope Protein gp41 (pharmacology), HIV-1 (chemistry), HIV-1 (drug effects), Molecular Sequence Data, Peptide Fragments (pharmacology), Protein Conformation, SARS Virus (chemistry), SARS Virus (drug effects), Viral Fusion Proteins (chemistry), Viral Fusion Proteins (genetics), Viral Fusion Proteins (metabolism).
- MESH :
- chemical , chemistry : Viral Fusion Proteins.
- chemical , genetics : Viral Fusion Proteins.
- chemical , metabolism : Viral Fusion Proteins.
- chemical , pharmacology : Anti-HIV Agents, Antiviral Agents, HIV Envelope Protein gp41, Peptide Fragments.
- chemistry : HIV-1, SARS Virus.
- drug effects : HIV-1, SARS Virus.
- Drug Design, Enfuvirtide, Molecular Sequence Data, Protein Conformation.
Abstract
Severe acute respiratory syndrome (SARS) is a febrile respiratory illness. The disease has been etiologically linked to a novel coronavirus that has been named the SARS-associated coronavirus (SARS-CoV), whose genome was recently sequenced. Since it is a member of the Coronaviridae, its spike protein (S2) is believed to play a central role in viral entry by facilitating fusion between the viral and host cell membranes. The protein responsible for viral-induced membrane fusion of HIV-1 (gp41) differs in length, and has no sequence homology with S2.
DOI: 10.1186/1471-2180-3-20
PubMed: 14499001
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003182
- to stream PubMed, to step Curation: 003182
- to stream PubMed, to step Checkpoint: 003299
- to stream Ncbi, to step Merge: 000344
- to stream Ncbi, to step Curation: 000344
- to stream Ncbi, to step Checkpoint: 000344
Links to Exploration step
pubmed:14499001Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.</title>
<author><name sortKey="Kliger, Yossef" sort="Kliger, Yossef" uniqKey="Kliger Y" first="Yossef" last="Kliger">Yossef Kliger</name>
<affiliation wicri:level="1"><nlm:affiliation>Compugen LTD, Tel Aviv, 69512, Israel. kliger@compugen.co.il</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Compugen LTD, Tel Aviv, 69512</wicri:regionArea>
<wicri:noRegion>69512</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Levanon, Erez Y" sort="Levanon, Erez Y" uniqKey="Levanon E" first="Erez Y" last="Levanon">Erez Y. Levanon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14499001</idno>
<idno type="pmid">14499001</idno>
<idno type="doi">10.1186/1471-2180-3-20</idno>
<idno type="wicri:Area/PubMed/Corpus">003182</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003182</idno>
<idno type="wicri:Area/PubMed/Curation">003182</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003182</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003299</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003299</idno>
<idno type="wicri:Area/Ncbi/Merge">000344</idno>
<idno type="wicri:Area/Ncbi/Curation">000344</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000344</idno>
<idno type="wicri:Area/Main/Merge">006555</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.</title>
<author><name sortKey="Kliger, Yossef" sort="Kliger, Yossef" uniqKey="Kliger Y" first="Yossef" last="Kliger">Yossef Kliger</name>
<affiliation wicri:level="1"><nlm:affiliation>Compugen LTD, Tel Aviv, 69512, Israel. kliger@compugen.co.il</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Compugen LTD, Tel Aviv, 69512</wicri:regionArea>
<wicri:noRegion>69512</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Levanon, Erez Y" sort="Levanon, Erez Y" uniqKey="Levanon E" first="Erez Y" last="Levanon">Erez Y. Levanon</name>
</author>
</analytic>
<series><title level="j">BMC microbiology</title>
<idno type="eISSN">1471-2180</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-HIV Agents (pharmacology)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Drug Design</term>
<term>Enfuvirtide</term>
<term>HIV Envelope Protein gp41 (pharmacology)</term>
<term>HIV-1 (chemistry)</term>
<term>HIV-1 (drug effects)</term>
<term>Molecular Sequence Data</term>
<term>Peptide Fragments (pharmacology)</term>
<term>Protein Conformation</term>
<term>SARS Virus (chemistry)</term>
<term>SARS Virus (drug effects)</term>
<term>Viral Fusion Proteins (chemistry)</term>
<term>Viral Fusion Proteins (genetics)</term>
<term>Viral Fusion Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Agents antiVIH (pharmacologie)</term>
<term>Antiviraux (pharmacologie)</term>
<term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Données de séquences moléculaires</term>
<term>Fragments peptidiques (pharmacologie)</term>
<term>Protéine d'enveloppe gp41 du VIH (pharmacologie)</term>
<term>Protéines de fusion virale ()</term>
<term>Protéines de fusion virale (génétique)</term>
<term>Protéines de fusion virale (métabolisme)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) ()</term>
<term>Virus du SRAS ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Viral Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Viral Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Viral Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-HIV Agents</term>
<term>Antiviral Agents</term>
<term>HIV Envelope Protein gp41</term>
<term>Peptide Fragments</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>HIV-1</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>HIV-1</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Protéines de fusion virale</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Protéines de fusion virale</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Agents antiVIH</term>
<term>Antiviraux</term>
<term>Fragments peptidiques</term>
<term>Protéine d'enveloppe gp41 du VIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Design</term>
<term>Enfuvirtide</term>
<term>Molecular Sequence Data</term>
<term>Protein Conformation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Données de séquences moléculaires</term>
<term>Protéines de fusion virale</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is a febrile respiratory illness. The disease has been etiologically linked to a novel coronavirus that has been named the SARS-associated coronavirus (SARS-CoV), whose genome was recently sequenced. Since it is a member of the Coronaviridae, its spike protein (S2) is believed to play a central role in viral entry by facilitating fusion between the viral and host cell membranes. The protein responsible for viral-induced membrane fusion of HIV-1 (gp41) differs in length, and has no sequence homology with S2.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006555 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 006555 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Merge |type= RBID |clé= pubmed:14499001 |texte= Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:14499001" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |